Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Paul Potach

Podiatrist Wheeling, IL Doctor of Podiatric Medicine

NPI 1073627410 CMS profile 906108

31 West Dundee, Wheeling, IL 60090

Open in the dashboard

General payments

$45,035

124 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Paul Potach of Wheeling, IL is reported in the CMS Open Payments database as having received $45,035 across 124 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $41,659 24
2024 General $835 17
2023 General $705 18
2022 General $1,287 24
2021 General $323 23
2020 General $170 14
2019 General $56 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul Potach
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to Paul Potach were reported at $41,659. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year Paul Potach Podiatrist median Middle half National median
2019 $56 $196 $72–$601 $163
2020 $170 $118 $38–$335 $114
2021 $323 $169 $57–$573 $132
2022 $1,287 $220 $74–$782 $149
2023 $705 $208 $71–$635 $160
2024 $835 $237 $87–$681 $164
2025 $41,659 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ConvaTec Inc. $40,764 11 payments
  2. Organogenesis Inc. $3,343 64 payments
  3. Horizon Therapeutics plc $485 38 payments
  4. Cardiovascular Systems Inc. $166 1 payment
  5. Nevro Corp. $146 1 payment
  6. Next Science LLC $59 3 payments
  7. Smith+Nephew, Inc. $15 1 payment
  8. Kowa Pharmaceuticals America, Inc. $14 1 payment
  9. IBSA Pharma Inc. $13 1 payment
  10. Novum Pharma, LLC $12 1 payment
  11. Other $18 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Debt forgiveness $40,764 11 payments
  2. Food and Beverage $4,258 112 payments
  3. Consulting Fee $13 1 payment
Products named General payments · program years 2019–2025
  1. INNOVAMATRIX AC $40,764 11 payments
  2. Puraply $1,726 35 payments
  3. SIMPLIMAX $464 7 payments
  4. DUEXIS $451 36 payments
  5. CYGNUS DUAL $400 7 payments
  6. Diamondback Peripheral $166 1 payment
  7. Senza $146 1 payment
  8. APLIGRAF $130 1 payment
  9. PURAPLY WOUND MATRIX $90 1 payment
  10. Affinity $87 1 payment
  11. Other $374 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

46

Median for Podiatry: 160

Drug cost

$673

Median for Podiatry: $2,368

Branded share of claims

0%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ketoconazole Generic 29 $559
Terbinafine Hcl Generic 17 $114

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$3,596,615

Medicare's payments for the services billed

Medicare patients

258

Average age 80

Services billed

2,731

145 women, 113 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Depression 39%
Diabetes 36%
Ischemic heart disease 33%
Chronic kidney disease 33%
Alzheimer's or dementia 30%
Heart failure 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

124 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record